Support services, biologist 14/15/16 for the genitourinary malignancies branch, center for cancer research, NCI. Base period: 05/16/2022 - 05/15/2023
Ended Awarded Last action
- Contract number
- 75N91022F00060
- Awardee
-
Astrix Technology LLC UEI NRVNN8E6NCK4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $124,384
Award facts
- Contract value 32% obligated
-
- $124,383.80 Current, with exercised options
- $391,822.80 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Red Bank, NJ, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $391,822.80 contract to Astrix Technology LLC, doing business as Astrix Technology Group, to provide biologist support services at the Genitourinary Malignancies Branch, Center for Cancer Research. The base period of performance is from May 16, 2022 to May 15, 2023, with a total potential performance period of 3 years through May 2025. This is a Blanket Purchase Agreement (BPA) call order under Astrix's existing Multiple Award Schedule (MAS) contract with the General Services Administration. The contract is for labor hours to support NCI's scientific research initiatives, with no set-aside designation indicated. Astrix Technology has a history of providing scientific, technical, and administrative support services to various NIH institutes and centers.
Quick answers
Who was awarded contract 75N91022F00060?
75N91022F00060 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on May 16, 2022.
How much is contract 75N91022F00060 worth?
The government has obligated $124,384 on 75N91022F00060. Its potential value, with all options, is $391,823.
Is contract 75N91022F00060 an order under another contract?
Yes. 75N91022F00060 is a BPA call under GS07F147DA-HHSN261201700002B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75N91022F00060 competed?
The extent of competition for 75N91022F00060 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award